EVAN CLARK: Open Payments
NPI 1083071443 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,685 in 101 payments from 17 companies in 2025. Trend: 2023 $2,512 · 2024 $2,386 · 2025 $1,685
Food & beverage: $1,685
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $317 |
| AstraZeneca Pharmaceuticals LP | 8 | $258 |
| ABBVIE INC. | 18 | $210 |
| Novartis Pharmaceuticals Corporation | 13 | $202 |
| Lilly USA, LLC | 10 | $141 |
| Amgen Inc. | 5 | $94 |
| PFIZER INC. | 4 | $72 |
| Sumitomo Pharma America, Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
Products named: FARXIGA, LEQVIO, MOUNJARO, UBRELVY, Rybelsus, Ozempic, OTEZLA, GEMTESA.
Industry payments across KY — which companies pay providers there.
